Effects of Chardonnay marc on heart health
Official title: Preclinical Trials to Determine the Range of Chardonnay Mark Intake for Improved Metabolic and Vascular Response.
Run by University of California, Davis · NCT05545865 · Data updated 2026-11-12
This study is testing whether eating products made with Chardonnay marc can improve heart health and how our bodies respond after meals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 50 Years |
| Sex | Men only |
| Enrollment | 5 (estimated) |
| Sponsor | University of California, Davis Academic / other |
| Locations | 1 site (Davis, California) |
| Status | Recruiting |
| Started | September 1, 2022 |
| Main results expected | August 24, 2026 |
| Study ends | August 24, 2026 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT05545865 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a BMI between 25.0 and 35 kg/m2 who have a Reactive Hyperemia Index (RHI) of less than 2.0.
✕Probably not a fit
Patients with a BMI of 35 kg/m2 or higher, those with certain blood conditions, or individuals with allergies to cocoa or grape products may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how products containing Chardonnay marc may influence cardiometabolic health by examining the postprandial vascular response in individuals. Participants will consume various cocoa products, and their responses will be monitored over a 6-hour period to assess the impact on vascular function and gut microbiome biomarkers. The study employs a crossover design with a small group of participants to minimize variability and ensure accurate data collection. The findings will inform future dietary intervention trials focused on the health benefits of Chardonnay marc.
Why it matters
Potential benefit: If successful, this study could lead to dietary recommendations that improve cardiovascular health through the consumption of Chardonnay marc.
How similar studies have gone: While there is limited data on the specific effects of Chardonnay marc, similar studies on cocoa flavanols have shown promising results in improving vascular function.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Screening or Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) \< 2.0 * Subject is willing and able to comply with the study protocols. * Subject is willing to participate in all study procedures * BMI 25.0 - 35 kg/m2 Exclusion Criteria: * BMI ≥ 35 kg/m2 * Indivduals that weight less than a 110 lbs * Donation of blood within the previous 30 days * Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) ≥ 2.0 * 1 ug/ml and 3 ug/ml collagen screening maximal platelet aggregatory response of \< 65%. * Platelet counts \< 150,000 / ul * Anemia, which includes self report, or a screening hemoglobin and hematocrit that is less than the normal reference range or as diagnosed by study physician upon review of complete blood cell count reports. * Dislike or allergy for nuts, cocoa or grape products * Self-reported use of daily anticoagulation agents including aspirin, NSAIDs * Vegan, Vegetarians, food faddists or those consuming a non-traditional diet * Fruit consumption ≥ 3 cups/day * Vegetable consumption ≥ 4 cups/day * Nut intake ≥ 2 servings/ week * Coffee/tea ≥ 3 cups/day * Dark chocolate ≥ 3 oz/day * Self-reported restriction of physical activity due to a chronic health condition * Self-reported chronic/routine high intensity exercise * Self-reported diabetes * Blood pressure ≥ 140/90 mm Hg * Self-reported renal or liver disease * Self-reported heart disease, which includes cardiovascular events and stroke * Peripheral artery disease, Raynaud's syndrome * Inability to properly place or wear the PAT probes or abnormal measurements on pre- screening PAT * Self-reported cancer within past 5 years * Self-reported malabsorption * Currently taking prescription drugs or supplements. * Supplement use or unwillingness to stop any supplement use, including herbal, plant or botanical, fish oil, oil supplements a month prior to study enrollment. * Indications of substance or alcohol abuse within the last 3 years * smoking, vaping, cannabis use * Current enrollee in a clinical research study.
Where it's running
-
Academic Surge, University of California, Davis
Davis, California, United States Recruiting
Study contacts
- Principal investigator: Carl L Keen — Distinguished Professor Emeritus of Nutrition
- Study coordinator: Roberta R Holt
- Email: rrholt@ucdavis.edu
- Phone: 5304005952
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how menopause affects heart disease risk
This study is trying to see how menopause affects heart disease risk in women by following them for at least 10 years and looking at changes in their heart and blood vessels.
-
Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
-
Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery
This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
-
AI-powered ECG to help diagnose and predict outcomes in heart disease
Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.
-
Training to reduce oxidative stress in knee OA
A six-week program compares supervised knee-strengthening training with a daily 6,000-step walking plan to see if it improves pain, function, and blood markers of cellular stress in people with knee osteoarthritis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.